| Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology DK Armstrong, RD Alvarez, JN Bakkum-Gamez, L Barroilhet, K Behbakht, ... Journal of the National Comprehensive Cancer Network 19 (2), 191-226, 2021 | 554 | 2021 |
| NCCN guidelines insights: Ovarian cancer, version 1.2019: Featured updates to the NCCN guidelines DK Armstrong, RD Alvarez, JN Bakkum-Gamez, L Barroilhet, K Behbakht, ... Journal of the National Comprehensive Cancer Network 17 (8), 896-909, 2019 | 254 | 2019 |
| Clinical trials and progress with paclitaxel in ovarian cancer S Kumar, H Mahdi, C Bryant, JP Shah, G Garg, A Munkarah International journal of women's health, 411-427, 2010 | 138 | 2010 |
| The role of frozen section in surgical staging of low risk endometrial cancer S Kumar, S Bandyopadhyay, A Semaan, JP Shah, H Mahdi, R Morris, ... PLoS One 6 (9), e21912, 2011 | 129 | 2011 |
| Predictors of surgical site infection in women undergoing hysterectomy for benign gynecologic disease: a multicenter analysis using the national surgical quality improvement … H Mahdi, S Goodrich, D Lockhart, R DeBernardo, M Moslemi-Kebria Journal of minimally invasive gynecology 21 (5), 901-909, 2014 | 128 | 2014 |
| Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center J Moline, H Mahdi, B Yang, C Biscotti, AA Roma, B Heald, PG Rose, ... Gynecologic oncology 130 (1), 121-126, 2013 | 116 | 2013 |
| Low-grade serous ovarian cancer: state of the science B Slomovitz, C Gourley, MS Carey, A Malpica, IM Shih, D Huntsman, ... Gynecologic oncology 156 (3), 715-725, 2020 | 107 | 2020 |
| Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary H Mahdi, RE Swensen, R Hanna, S Kumar, R Ali-Fehmi, A Semaan, ... British journal of cancer 105 (4), 493-497, 2011 | 104 | 2011 |
| CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors C Saygin, A Wiechert, VS Rao, R Alluri, E Connor, PS Thiagarajan, ... Journal of Experimental Medicine 214 (9), 2715-2732, 2017 | 92 | 2017 |
| The impact of obesity on the 30-day morbidity and mortality after surgery for endometrial cancer H Mahdi, AM Jernigan, Q Aljebori, D Lockhart, M Moslemi-Kebria Journal of minimally invasive gynecology 22 (1), 94-102, 2015 | 75 | 2015 |
| Surgical site infection in women undergoing surgery for gynecologic cancer H Mahdi, A Gojayev, M Buechel, J Knight, J SanMarco, D Lockhart, ... International Journal of Gynecologic Cancer 24 (4), 2014 | 72 | 2014 |
| Prognostic impact of marital status on survival of women with epithelial ovarian cancer H Mahdi, S Kumar, AR Munkarah, M Abdalamir, M Doherty, R Swensen Psycho‐Oncology 22 (1), 83-88, 2013 | 63 | 2013 |
| Germline PTEN, SDHB‐D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden‐like syndromes: An international, multicenter … H Mahdi, JL Mester, EA Nizialek, J Ngeow, C Michener, C Eng Cancer 121 (5), 688-696, 2015 | 62 | 2015 |
| Tumor size is an independent predictor of lymph node metastasis and survival in early stage endometrioid endometrial cancer H Mahdi, AR Munkarah, R Ali-Fehmi, J Woessner, SN Shah, ... Archives of Gynecology and Obstetrics 292, 183-190, 2015 | 60 | 2015 |
| Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition S Cascio, C Chandler, L Zhang, S Sinno, B Gao, S Onkar, TC Bruno, ... Science advances 7 (46), eabi5790, 2021 | 53 | 2021 |
| Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors X Wang, C Barrera, K Bera, VS Viswanathan, S Azarianpour-Esfahani, ... Science Advances 8 (22), eabn3966, 2022 | 48 | 2022 |
| Ceralasertib-mediated ATR inhibition combined with olaparib in advanced cancers harboring DNA damage response and repair alterations (olaparib combinations) H Mahdi, N Hafez, D Doroshow, D Sohal, V Keedy, KT Do, P LoRusso, ... JCO Precision Oncology 5, 1432-1442, 2021 | 47 | 2021 |
| Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence? I Winer, QF Ahmed, I Mert, S Bandyopadhyay, M Cote, AR Munkarah, ... International Journal of Gynecological Pathology 34 (1), 47-56, 2015 | 44 | 2015 |
| Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study MA Elshaikh, Z Al-Wahab, H Mahdi, K Albuquerque, M Mahan, SM Kehoe, ... Gynecologic oncology 136 (2), 235-239, 2015 | 43 | 2015 |
| Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma H Mahdi, M Moslemi-Kebria, KL Levinson, A Gojayev, D Lockhart, ... International Journal of Gynecologic Cancer 23 (7), 2013 | 43 | 2013 |
